title: Use of low-dose selective serotonin reuptake inhibitors for severe, refractory choking phobia in childhood.
abstract: Difficulty swallowing solids and/or liquids accompanied by intense anxiety that results in restricted eating patterns or complete avoidance of eating may not have an easily identified underlying medical cause. This type of "eating disorder," which has also been described as "choking phobia," may occur in the absence of body image distortion, fear of becoming fat, or the desire to be thinner. The primary complaint in these children may be physical discomfort accompanied by high anxiety. Negative consequences can be severe and include social withdrawal, family distress, and deleterious effects on the child's physical health. Prompt recognition in the pediatric setting is, therefore, critical to avoid escalation of symptoms and treatment delays. Three pediatric cases of severe choking phobia refractory to prior intervention are presented in which rapid and sustained improvement followed low-dose therapy with a selective serotonin reuptake inhibitor (SSRI). Possible predictors of response to low-dose SSRI treatment in children with choking phobia and future avenues for investigation are explored.
authors.affiliation: Department of Psychiatry and Behavioral Neurosciences, Wayne State University, Detroit, MI 48201, USA.
authors.forename: S Preeya
authors.initials: SP
authors.lastname: Banerjee
authors.forename: Rashmi P
authors.initials: RP
authors.lastname: Bhandari
authors.forename: David R
authors.initials: DR
authors.lastname: Rosenberg
mesh_terms: D002648:Child; D004305:Dose-Response Relationship, Drug; D001068:Feeding and Eating Disorders / Q000139:chemically induced*; D005260:Female; D006801:Humans; D008297:Male; D010698:Phobic Disorders / Q000139:chemically induced*; D017367:Selective Serotonin Reuptake Inhibitors / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D017367:Selective Serotonin Reuptake Inhibitors